Actively Recruiting
Remote ECG Monitoring Post TAVI
Led by Medical University of Silesia · Updated on 2026-04-13
250
Participants Needed
4
Research Sites
217 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The DRAGON TAVI study is a multicenter, prospective, open, randomised trial, which will enrol 250 patients, randomized 1:1 to the study group (continuous 30-day ECG monitoring with visits triggered by ECG findings) and standard care (ie. control group, which will receive the standard post op 24-48h ECG monitoring and a regular follow-up visit with standard ECG within 30 days). The duration of the study is 12 months ± 1 month.
CONDITIONS
Official Title
Remote ECG Monitoring Post TAVI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient age over 18 years old
- Severe aortic stenosis
- Moderate or high cardiovascular risk based on current ESC Guidelines "Heart Team" qualification for TAVI
- Written informed consent of the patient for participation in the study
You will not qualify if you...
- History of atrial fibrillation or atrial flutter
- Previously known conduction disturbances
- Presence of pacemaker, CRT-P, ICD, CRT-D before or after TAVI
- Ischaemic stroke, TIA, MI or heart surgery within 1 month before TAVI qualification
- Haemorrhagic stroke within 1 year before TAVI qualification
- Chronic immunosuppressive therapy
- Comorbidities such as drug addiction, alcohol abuse, or emotional/mental disorders preventing safe participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Division of Cardiology, Departement of Medical Science University of Turin, Città della Salute e Della Scienza
Turin, Italy
Actively Recruiting
2
Department of Invasive Cardiology, Medical University of Białystok, Bialystok, Poland
Bialystok, Poland
Actively Recruiting
3
Medical University of Silesia
Katowice, Poland, 40-055
Actively Recruiting
4
Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland
Katowice, Poland, 40-635
Not Yet Recruiting
Research Team
W
Wojciech Wańha, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here